Bromethalin is described as an alternative rodenticide to warfarin. Its primary mechanism is which?

Get ready for the ACVPM Toxicology Exam with our comprehensive quiz. Enhance your knowledge with multiple-choice questions and detailed explanations. Prepare effectively for your certification exam!

Multiple Choice

Bromethalin is described as an alternative rodenticide to warfarin. Its primary mechanism is which?

Explanation:
Bromethalin works by uncoupling oxidative phosphorylation in mitochondria, particularly in brain cells. By dissipating the proton gradient across the inner mitochondrial membrane, it stops ATP production even though electron transport continues. The resulting ATP depletion impairs energy-dependent processes, including the Na+/K+-ATPase pump, leading to cellular swelling and cerebral edema. The central nervous system is especially sensitive, so this energy failure manifests as tremors, hyperexcitability, and seizures. This mechanism is different from anticoagulant rodenticides that inhibit vitamin K recycling, and it’s not a glycine receptor antagonist or acetylcholinesterase inhibitor, which would cause other toxic effects. Bromethalin’s hallmark is mitochondrial uncoupling and neural energy failure.

Bromethalin works by uncoupling oxidative phosphorylation in mitochondria, particularly in brain cells. By dissipating the proton gradient across the inner mitochondrial membrane, it stops ATP production even though electron transport continues. The resulting ATP depletion impairs energy-dependent processes, including the Na+/K+-ATPase pump, leading to cellular swelling and cerebral edema. The central nervous system is especially sensitive, so this energy failure manifests as tremors, hyperexcitability, and seizures. This mechanism is different from anticoagulant rodenticides that inhibit vitamin K recycling, and it’s not a glycine receptor antagonist or acetylcholinesterase inhibitor, which would cause other toxic effects. Bromethalin’s hallmark is mitochondrial uncoupling and neural energy failure.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy